qWERtyUi Patient Report   

Specimen ID: 244-216-2262-0 Acct #: 09682002 Phone: (407) 292-0292 Rte: 22

Control ID: 24889597-2
Rosemont Family Medical Center
HENDRYX, ROBERT 5554 CLARCONA-OCOEE RD.
8700 MAITLAND SUMMIT BLVD ORLANDO FL 32810




















ORLANDO FL 32810
(813) 951-6972

Patient Details Specimen Details Physician Details

DOB: 10/26/1987 Date collected: 09/01/2017 0811 Local Ordering: K ROWE ARNP
Age(y/m/d): 029/10/06 Date received: 09/01/2017 Referring:
Gender: M SSN: ***-**-7002 Date entered: 09/01/2017 ID: 1023349677
Patient ID: 520025 Date reported: 09/02/2017 0821 ET NPI: 1023349677
General Comments & Additional Information
Alternate Control Number: 24889597-2 Alternate Patient ID: 520025
Total Volume: Not Provided Fasting: Yes
Ordered Items
Comp. Metabolic Panel (14); Lipid Panel With LDL/HDL Ratio; Venipuncture; Cardiovascular Report
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
Comp. Metabolic Panel (14)
Glucose, Serum 80 mg/dL 65 - 99 01
BUN 20 mg/dL 6 - 20 01
Creatinine, Serum 1.14 mg/dL 0.76 - 1.27 01
eGFR If NonAfricn Am 86 mL/min/1.73 >59
eGFR If Africn Am 100 mL/min/1.73 >59
BUN/Creatinine Ratio 18 9 - 20
Sodium, Serum 137 mmol/L 134 - 144 01
Potassium, Serum 4.4 mmol/L 3.5 - 5.2 01
Chloride, Serum 97 mmol/L 96 - 106 01
Carbon Dioxide, Total 23 mmol/L 18 - 29 01
Calcium, Serum 9.6 mg/dL 8.7 - 10.2 01
Protein, Total, Serum 7.3 g/dL 6.0 - 8.5 01
Albumin, Serum 4.7 g/dL 3.5 - 5.5 01
Globulin, Total 2.6 g/dL 1.5 - 4.5
A/G Ratio 1.8 1.2 - 2.2
Bilirubin, Total 0.7 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase, S 48 IU/L 39 - 117 01
AST (SGOT) 28 IU/L 0 - 40 01
ALT (SGPT) 46 High IU/L 0 - 44 01

Lipid Panel With LDL/HDL Ratio

Cholesterol, Total 198 mg/dL 100 - 199 01
Triglycerides 76 mg/dL 0 - 149 01
HDL Cholesterol 47 mg/dL >39 01
VLDL Cholesterol Cal 15 mg/dL 5 - 40
LDL Cholesterol Calc 136 High mg/dL 0 - 99
LDL/HDL Ratio 2.9 ratio units 0.0 - 3.6
Please Note: 01
LDL/HDL Ratio

Date Issued: 09/02/17 0828 ET FINAL REPORT Page 1 of 2

This document contains private and confidential health information protected by state and federal law. © 1995-2017 Laboratory Corporation of America® Holdings
If you have received this document in error, please call 800-877-5227 1.00
All Rights Reserved - Enterprise Report Version:          
qWERtyUi Patient Report   
Patient: HENDRYX, ROBERT Specimen ID: 244-216-2262-0
DOB: 10/26/1987 Patient ID: 520025 Control ID: 24889597-2 Date collected: 09/01/2017 0811 Local

TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB

Men Women
1/2 [Link] 1.0 1.5
[Link] 3.6 3.2
2X [Link] 6.2 5.0
3X [Link] 8.0 6.1

Cardiovascular Report
Interpretation Note 02
Supplement report is available.
PDF Image . 02

01 TA LabCorp Tampa Dir: Sean Farrier, MD

5610 W LaSalle Street, Tampa, FL 33607-1770
02 LITIL Litholink Corporation Dir: Mitchell Laks, PhD
2250 West Campbell Park Drive, Chicago, IL 60612-3502
For inquiries, the physician may contact Branch: 800-877-5227 Lab: 800-877-5227

Date Issued: 09/02/17 0828 ET FINAL REPORT Page 2 of 2

This document contains private and confidential health information protected by state and federal law. © 1995-2017 Laboratory Corporation of America® Holdings
If you have received this document in error, please call 800-877-5227 1.00
All Rights Reserved - Enterprise Report Version:          
PATIENT DATE OF BIRTH GENDER DATE OF SERVICE PHYSICIAN Litholink Patient Results Report
HENDRYX, ROBERT 10/26/1987 M 09/01/2017 ROWE, KIRSTEN
LabCorp Account #: 09682002

Patient Results Summary

Cholesterol comes in different forms and has varying effects on your heart health. Some cholesterol is “good” and not known to
cause disease, this is HDL. The rest of cholesterol causes disease by clogging your arteries, this is non-HDL. LDL cholesterol is the
largest component of the non-HDL cholesterol. Lowering your levels of “bad” cholesterol will lower your risk for disease.
LDL cholesterol (LDL-C) is the largest component of the non-HDL cholesterol (“bad” cholesterol).
non-HDL is composed of many different types of cholesterol (not just LDL-C) and high levels cause disease.

The level to which your LDL must be lowered depends on the risk for developing heart disease or having a heart attack. The
higher your risk for heart disease, the lower your LDL goal.

Contributing Risk Factors For Heart Disease

Heart and/or vascular disease Cigarette (tobacco) smoking
High blood pressure Low HDL (men less than 40 mg/dL, women less than 50 mg/dL)
Diabetes Family history of early onset heart disease
Chronic kidney disease Man over 45 years or woman over 55 years
Obesity Familial Hypercholesterolemia

Your Heart Disease Risk Category

Selected by your physician based upon your risk factors and clinical judgement.
Test /
Your Results Low Intermediate High
LDL-C
136 mg/dL 160 100 130 70 100

non-HDL
151 mg/dL 190 130 160 100 130

= Your Result: Left (Green) = Optimal, Center = Acceptable, Right (Red) = High Risk

Your Care Plan (as selected by your physician)

Eat less trans fats and saturated fats, red Control any other medical conditions: such as diabetes, high blood
meat, and sugary foods/drinks pressure
Eat more vegetables, fruits, whole grains, low- Visit your doctor as scheduled and obtain all follow-up tests/treatments
fat dairy products, poultry, fish, and nuts recommended
Exercise Take all of your medications your doctor(s) have prescribed
Lose weight
DISCLAIMER:You should discuss this information with your physician. Litholink does not have a doctor-patient relationship with you, nor does it have access to a complete
medical history or a physical examination that would be necessary for a complete diagnosis and comprehensive treatment plan. Neither you nor your physician should rely
solely on this guidance. REFERENCES: National Heart, Lung, and Blood Institute’s Third Report of the NCEP Expert Panel on Detection, Evaluation and Treatment of High Blood
Cholesterol in Adults (ATP III) (2002. NIH publication 02-5215); National Heart, Lung, and Blood Institute’s Your Guide to Lowering Your Cholesterol with TLC (2005. NIH
publication 06-5235); Stone NJ et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the
American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 00:000-000.

Mitchell S. Laks, PhD Litholink, A LabCorp Company 800 338 4333 Telephone Version: 7.4.8.4730
Laboratory Director 2250 West Campbell Park Drive 866 361 7939 Facsimile Printed: 09/02/2017
CLIA# 14D0897314 Chicago, Illinois 60612 [Link] Page: 1 of 1